These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31063999)

  • 21. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia.
    Kang SG; Lee HJ; Park YM; Yang HJ; Song HM; Lee YJ; Cho SJ; Cho SN; Kim L
    Hum Psychopharmacol; 2013 Mar; 28(2):117-23. PubMed ID: 23361623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome.
    Jiménez-Jiménez FJ; Alonso-Navarro H; Martínez C; Zurdo M; Turpín-Fenoll L; Millán-Pascual J; Adeva-Bartolomé T; Cubo E; Navacerrada F; Rojo-Sebastián A; Rubio L; Calleja M; Plaza-Nieto JF; Pilo-de-la-Fuente B; Arroyo-Solera M; García-Martín E; Agúndez JA
    Sleep Med; 2014 Feb; 15(2):266-8. PubMed ID: 24424098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of Association between Genetic Risk Loci for Restless Legs Syndrome and Multimorbidity.
    Szentkirályi A; Völzke H; Hoffmann W; Winkelmann J; Berger K
    Sleep; 2016 Jan; 39(1):111-5. PubMed ID: 26350469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood cis-eQTL analysis fails to identify novel association signals among sub-threshold candidates from genome-wide association studies in restless legs syndrome.
    Schulte EC; Schramm K; Schurmann C; Lichtner P; Herder C; Roden M; Gieger C; Peters A; Trenkwalder C; Högl B; Frauscher B; Berger K; Fietze I; Gross N; Stiasny-Kolster K; Oertel W; Bachmann CG; Paulus W; Zimprich A; Völzke H; Schminke U; Nauck M; Illig T; Meitinger T; Müller-Myhsok B; Prokisch H; Winkelmann J
    PLoS One; 2014; 9(5):e98092. PubMed ID: 24875634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic markers of Restless Legs Syndrome in Parkinson disease.
    Gan-Or Z; Alcalay RN; Bar-Shira A; Leblond CS; Postuma RB; Ben-Shachar S; Waters C; Johnson A; Levy O; Mirelman A; Gana-Weisz M; Dupré N; Montplaisir J; Giladi N; Fahn S; Xiong L; Dion PA; Orr-Urtreger A; Rouleau GA
    Parkinsonism Relat Disord; 2015 Jun; 21(6):582-5. PubMed ID: 25817513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of candidate genetic variants with restless legs syndrome in end stage renal disease: a multicenter case-control study in Taiwan.
    Lin CH; Chen ML; Wu VC; Li WY; Sy HN; Wu SL; Chang CC; Chiu PF; Liou HH; Lin CY; Chang HW; Lin SY; Wu KD; Chen YM; Wu RM
    Eur J Neurol; 2014 Mar; 21(3):492-8. PubMed ID: 24433515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome.
    Yang Q; Li L; Yang R; Shen GQ; Chen Q; Foldvary-Schaefer N; Ondo WG; Wang QK
    Mov Disord; 2011 Feb; 26(3):516-9. PubMed ID: 21264940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson's Disease with Opposite Effects.
    Mohtashami S; He Q; Ruskey JA; Zhou S; Dion PA; Allen RP; Earley CJ; Fon EA; Xiong L; Dupre N; Dauvilliers Y; Rouleau GA; Gan-Or Z
    J Mol Neurosci; 2018 Mar; 64(3):341-345. PubMed ID: 29404899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease.
    Schormair B; Plag J; Kaffe M; Gross N; Czamara D; Samtleben W; Lichtner P; Ströhle A; Stefanidis I; Vainas A; Dardiotis E; Sakkas GK; Gieger C; Müller-Myhsok B; Meitinger T; Heemann U; Hadjigeorgiou GM; Oexle K; Winkelmann J
    J Med Genet; 2011 Jul; 48(7):462-6. PubMed ID: 21572129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic studies of DMT1 on 12q in French-Canadian restless legs syndrome patients and families.
    Xiong L; Dion P; Montplaisir J; Levchenko A; Thibodeau P; Karemera L; Rivière JB; St-Onge J; Gaspar C; Dubé MP; Desautels A; Turecki G; Rouleau GA
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):911-7. PubMed ID: 17510944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.
    Roco A; Jiménez-Jiménez FJ; Alonso-Navarro H; Martínez C; Zurdo M; Turpín-Fenoll L; Millán J; Adeva-Bartolomé T; Cubo E; Navacerrada F; Rojo-Sebastián A; Rubio L; Calleja M; Plaza-Nieto JF; Pilo-de-la-Fuente B; Arroyo-Solera M; García-Martín E; Agúndez JA
    J Neural Transm (Vienna); 2013 Mar; 120(3):463-7. PubMed ID: 23001634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNCA-Rep1 polymorphism correlates with susceptibility and iron deficiency in restless legs syndrome.
    Zhu XY; Wang HM; Wu TT; Liu T; Chen YJ; Li X; Chen TJ; Liu Y; Zhang XJ; Wang XX; Zhang Y; Ondo WG; Wu YC
    Parkinsonism Relat Disord; 2020 Dec; 81():12-17. PubMed ID: 33035800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia.
    Jung JS; Lee HJ; Cho CH; Kang SG; Yoon HK; Park YM; Moon JH; Yang HJ; Song HM; Kim L
    Chronobiol Int; 2014 Aug; 31(7):838-44. PubMed ID: 24824748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study.
    Vávrová J; Kemlink D; Sonka K; Havrdová E; Horáková D; Pardini B; Müller-Myhsok B; Winkelmann J
    Sleep Med; 2012 Aug; 13(7):848-51. PubMed ID: 22609020
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Jiménez-Jiménez FJ; Gómez-Tabales J; Alonso-Navarro H; Rodríguez C; Turpín-Fenoll L; Millán-Pascual J; Álvarez I; Pastor P; Calleja M; García-Ruiz R; Navarro-Muñoz S; Recio-Bermejo M; Plaza-Nieto JF; García-Albea E; García-Martín E; Agúndez JAG
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic association studies of neurotensin gene and restless legs syndrome in French Canadians.
    Xiong L; Levchenko A; Montplaisir J; Rivière JB; Thibodeau P; St-Onge J; Gaspar C; Desautels A; Lespérance P; Chouinard S; Turecki G; Rouleau GA
    Sleep Med; 2008 Mar; 9(3):273-82. PubMed ID: 17644423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epidemiological characterization of restless legs syndrome in Québec.
    Akçimen F; Ross JP; Sarayloo F; Liao C; De Barros Oliveira R; Ruskey JA; Bourassa CV; Dion PA; Xiong L; Gan-Or Z; Rouleau GA
    Sleep; 2020 Apr; 43(4):. PubMed ID: 31665514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels.
    Xiong L; Catoire H; Dion P; Gaspar C; Lafrenière RG; Girard SL; Levchenko A; Rivière JB; Fiori L; St-Onge J; Bachand I; Thibodeau P; Allen R; Earley C; Turecki G; Montplaisir J; Rouleau GA
    Hum Mol Genet; 2009 Mar; 18(6):1065-74. PubMed ID: 19126776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large genome-wide association study identifies three novel risk variants for restless legs syndrome.
    Didriksen M; Nawaz MS; Dowsett J; Bell S; Erikstrup C; Pedersen OB; Sørensen E; Jennum PJ; Burgdorf KS; Burchell B; Butterworth AS; Soranzo N; Rye DB; Trotti LM; Saini P; Stefansdottir L; Magnusson SH; Thorleifsson G; Sigmundsson T; Sigurdsson AP; Van Den Hurk K; Quee F; Tanck MWT; Ouwehand WH; Roberts DJ; Earley EJ; Busch MP; Mast AE; Page GP; Danesh J; Di Angelantonio E; Stefansson H; Ullum H; Stefansson K
    Commun Biol; 2020 Nov; 3(1):703. PubMed ID: 33239738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TOX3 gene variant could be associated with painful restless legs.
    Karroum EG; Saini PS; Trotti LM; Rye DB
    Sleep Med; 2020 Jan; 65():4-7. PubMed ID: 31706190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.